Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 0

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 0
---
Filed Pursuant to Rule 424(b)(3)
Registration No. 333-284816 MERGER PROPOSED—YOUR VOTE IS IMPORTANT Dear Enfusion, Inc. Stockholder: On January 10, 2025, Enfusion, Inc. (“ Enfusion”), Clearwater Analytics Holdings, Inc. (“ Clearwater”), Enfusion Ltd. LLC, a subsidiary of Enfusion (“ Enfusion OpCo”), Poseidon Acquirer, Inc., a wholly-owned subsidiary of Clearwater (“ Acquirer”), Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of Clearwater (“ Merger Sub”), and Poseidon Merger Sub II, LLC, an indirect subsidiary of Clearwater (“ Merger Sub II”), entered into an Agreement and Plan of Merger (as it may be amended from time to time, the “ Merger Agreement”). Pursuant to the terms of the Merger Agreement, (i) Merger Sub II will merge with and into Enfusion OpCo (the “ LLC Merger”), with Enfusion OpCo surviving the LLC Merger as an indirect subsidiary of Clearwater, (ii) Merger Sub will merge with and into Enfusion (the “ Merger”), with Enfusion surviving the Merger as a direct, wholly-owned subsidiary of Clearwater (the “ Surviving Corporation”), and (iii) subject to satisfaction of certain conditions in the Merger Agreement, the Surviving Corporation will merge with and into Acquirer (the “ Second Merger” and, together with the Merger, the “ Corporate Mergers” and the Corporate Mergers, together with the LLC Merger, the “ Mergers”), with Acquirer surviving the Second Merger as a direct, wholly-owned subsidiary of Clearwater. If the Second Merger does not occur, references to the “Mergers” herein will mean the Merger and the LLC Merger. Upon the terms and subject to the conditions set forth in the Merger Agreement, (i) at the effective time of the Merger (the “ Effective Time”), each (x) share of Class A common stock of Enfusion, par value $0.001 per share, that is issued and outstanding immediately prior to the Effective Time (other than shares owned by Enfusion, Clearwater or any of their respective wholly-owned subsidiaries, in each case not held on behalf of third parties) (“ Enfusion Common Stock”) and (y) restricted stock unit of Enfusion that is vested as of immediately prior to the Effective Time or that vests